全文获取类型
收费全文 | 69576篇 |
免费 | 7428篇 |
国内免费 | 5099篇 |
专业分类
耳鼻咽喉 | 799篇 |
儿科学 | 903篇 |
妇产科学 | 734篇 |
基础医学 | 6838篇 |
口腔科学 | 1585篇 |
临床医学 | 8874篇 |
内科学 | 8974篇 |
皮肤病学 | 581篇 |
神经病学 | 2892篇 |
特种医学 | 2642篇 |
外国民族医学 | 30篇 |
外科学 | 6607篇 |
综合类 | 14961篇 |
现状与发展 | 14篇 |
一般理论 | 3篇 |
预防医学 | 5654篇 |
眼科学 | 1568篇 |
药学 | 8268篇 |
100篇 | |
中国医学 | 5081篇 |
肿瘤学 | 4995篇 |
出版年
2024年 | 361篇 |
2023年 | 1339篇 |
2022年 | 3261篇 |
2021年 | 3964篇 |
2020年 | 3033篇 |
2019年 | 2275篇 |
2018年 | 2372篇 |
2017年 | 2368篇 |
2016年 | 2125篇 |
2015年 | 3409篇 |
2014年 | 4144篇 |
2013年 | 4145篇 |
2012年 | 5879篇 |
2011年 | 6267篇 |
2010年 | 4583篇 |
2009年 | 3872篇 |
2008年 | 4230篇 |
2007年 | 4148篇 |
2006年 | 3825篇 |
2005年 | 3262篇 |
2004年 | 2504篇 |
2003年 | 2233篇 |
2002年 | 1945篇 |
2001年 | 1442篇 |
2000年 | 1136篇 |
1999年 | 901篇 |
1998年 | 534篇 |
1997年 | 518篇 |
1996年 | 358篇 |
1995年 | 326篇 |
1994年 | 277篇 |
1993年 | 176篇 |
1992年 | 166篇 |
1991年 | 144篇 |
1990年 | 157篇 |
1989年 | 101篇 |
1988年 | 80篇 |
1987年 | 58篇 |
1986年 | 58篇 |
1985年 | 47篇 |
1984年 | 37篇 |
1983年 | 18篇 |
1982年 | 5篇 |
1981年 | 8篇 |
1980年 | 4篇 |
1979年 | 7篇 |
1976年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Zeyu Li Erwei Hao Rui Cao Si Lin Linghui Zou Tianyan Huang Zhengcai Du Xiaotao Hou Jiagang Deng 《中草药(英文版)》2022,14(4):479-493
Zedoary tumeric (Curcumae Rhizoma, Ezhu in Chinese) has a long history of application and has great potential in the treatment of liver cancer. The anti liver cancer effect of zedoary tumeric depends on the combined action of multiple pharmacodynamic substances. In order to clarify the specific mechanism of zedoary tumeric against liver cancer, this paper first analyzes the mechanism of its single pharmacodynamic substance against liver cancer, and then verifies the joint anti liver cancer mechanism of its "pharmacodynamic group". By searching the research on the anti hepatoma effect of active components of zedoary tumeric in recent years, we found that pharmacodynamic substances, including curcumol, zedoarondiol, curcumenol, curzerenone, curdione, curcumin, germacrone, β-elemene, can act on multi-target and multi-channel to play an anti hepatoma role. For example, curcumin can regulate miR, GLO1, CD133, VEGF, YAP, LIN28B, GPR81, HCAR-1, P53 and PI3K/Akt/mTOR, HSP70/TLR4 and NF-κB. Wnt/TGF/EMT, Nrf2/Keap1, JAK/STAT and other pathways play an anti hepatoma role. Network pharmacological analysis showed that the core targets of the "pharmacodynamic group" for anti-life cancer are AKT1, EGFR, MAPK8, etc, and the core pathways are neuroactive live receiver interaction, nitrogen metabolism, HIF-1 signaling pathway, etc. At the same time, by comparing and analyzing the relationship between the specific mechanisms of pharmacodynamic substance and "pharmacodynamic group", it is found that they have great reference significance in target, pathway, biological function, determination of core pharmacodynamic components, formation of core target protein interaction, in-depth research of single pharmacodynamic substance, increasing curative effect and so on. By analyzing the internal mechanism of zedoary tumeric pharmacodynamic substance and "pharmacodynamic group" in the treatment of liver cancer, this paper intends to provide some ideas and references for the deeper pharmacological research of zedoary tumeric and the relationship between pharmacodynamic substance and "pharmacodynamic group". 相似文献
3.
Clinical and Experimental Medicine - Recently, the use of novel targeted drugs significantly improved the overall response rate (ORR) and survival of patients with relapsed/refractory chronic... 相似文献
4.
5.
Xin Yi Wong Andrew Qi Jun Lim Qianyu Shen John Whay Kuang Chia Min Hoe Chew Wah Siew Tan 《Current medical research and opinion》2020,36(10):1677-1686
Abstract
Objective
Ras wild-type metastatic colorectal cancers (mCRC) may be treated with anti-vascular endothelial growth factor (VEGF) or anti-epidermal growth factor receptor (EGFR) agents. We aim to estimate patients’ preferences for mCRC treatment and relative importance of cost, efficacy improvement, avoidance of side effects and therapy convenience, and relative uptake between profiles that resemble Bevacizumab (anti-VEGF) and Cetuximab (anti-EGFR), two commonly prescribed mCRC targeted therapies. 相似文献6.
7.
Sophocarpine attenuates toll‐like receptor 4 in steatotic hepatocytes to suppress pro‐inflammatory cytokines synthesis
下载免费PDF全文
![点击此处可从《Journal of gastroenterology and hepatology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
8.
9.